What is EpiphanyRx?
EpiphanyRx is a next-generation pharmacy benefit management (PBM) solution tailored for employers, with a particular focus on the emerging and mid-market segments. The company differentiates itself by aligning its business model with client objectives, emphasizing revenue transparency and delivering substantial cost savings. EpiphanyRx is committed to high-quality service and proactive communication, ensuring members are treated with care and integrity. A core tenet of its operation is complete transparency, offering a 100% pass-through of drug discounts and rebates, thereby eliminating potential conflicts of interest.
How much funding has EpiphanyRx raised?
EpiphanyRx has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in EpiphanyRx
PPP
Public-Private Partnership
What's next for EpiphanyRx?
The substantial capital infusion, indicated by the $150K in total funding and the recent strategic investment, positions EpiphanyRx for significant scaling and market expansion. As a company operating in the late-stage funding phase, EpiphanyRx is likely to focus on enhancing its technological infrastructure, broadening its client base, and potentially exploring strategic partnerships to further solidify its market position. The emphasis on transparency and cost savings suggests a continued drive to disrupt traditional PBM models and capture greater market share through superior value propositions.
See full EpiphanyRx company page
